TOP STORIES
respiratory
Lung cancer

Advanced mesothelioma: frontline chemoimmunotherapy shows promise in DREAM trial


A combination of durvalumab and standard first-line chemotherapy has shown promise for the management of untreated patients with advanced mesothelioma unsuitable for surgery. The phase 2 single-arm Australian study, published in The Lancet Oncology, is the first clinical trial reporting...

A combination of durvalumab and standard first-line chemotherapy has shown promise for the management of untreated patients with advanced mesothelioma...

Read more